ArticleAnnals of surgical oncology2025
Quality of Life in Oropharyngeal Cancer: A Retrospective Analysis of Patient Characteristics and Treatment Modalities.
Article in Annals of surgical oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
19 authors.
Funding
Abstract
backgroundIn patients with oropharyngeal squamous cell carcinoma (OPSCC), understanding the factors affecting post-treatment quality of life (QoL) is essential for optimizing long-term management. This study aimed to evaluate the impact of patient characteristics and treatment modalities on post-treatment QoL in patients with OPSCC. PATIENTS AND
methodsA total of 303 patients with OPSCC who completed treatment were assessed for QoL between August 2023 and January 2024 using various validated questionnaires. In addition, patient charts were reviewed.
resultsLower QoL was associated with older age, female sex, lower education, reduced income, fewer household members, unemployment, less than 5 years since diagnosis, advanced stage, disease recurrence, and human papillomavirus (HPV)-negative status. Robotic surgery and surgery alone were associated with better QoL than conventional surgery or surgery with adjuvant therapy. Radiotherapy is associated with additional issues, such as dry mouth and sticky saliva. Fewer patients who underwent surgery with adjuvant therapy reported tooth and dry mouth issues than those who received definitive chemoradiotherapy. In subgroup analyses, QoL in HPV-positive patients mirrored that of the overall cohort, whereas no significant differences were noted between treatment modalities in HPV-negative patients. Similarly, in the early stage group, HPV-positive patients had better QoL than HPV-negative patients; however, no significant differences were observed on the basis of HPV status or treatment modality in advanced-stage patients.
conclusionsSociodemographic factors, clinicopathological characteristics, and treatment modalities significantly impacted the post-treatment QoL of patients with OPSCC. Individualized treatment planning and comprehensive post-treatment care are crucial for optimizing QoL, particularly in patients at higher risk of poorer outcomes.
Indexed as
Identifiers
41028641What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.